A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset.
Nishiyama
S
S
Department of Neurology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan. snishym@em.neurol.med.tohoku.ac.jp
Ito
T
T
Misu
T
T
Takahashi
T
T
Kikuchi
A
A
Suzuki
N
N
Jin
K
K
Aoki
M
M
Fujihara
K
K
Itoyama
Y
Y
D000328:Adult; D017668:Age of Onset; D051401:Aquaporin 4 / Q000276:immunology*; D001253:Astrocytes / Q000276:immunology / Q000473:pathology; D001323:Autoantibodies / Q000032:analysis / Q000097:blood*; D015415:Biomarkers / Q000032:analysis / Q000097:blood; D001812:Blood-Brain Barrier / Q000276:immunology / Q000503:physiopathology; D018450:Disease Progression; D005260:Female; D006801:Humans; D007564:Japan; D008279:Magnetic Resonance Imaging; D008775:Methylprednisolone / Q000627:therapeutic use; D009471:Neuromyelitis Optica / Q000097:blood* / Q000175:diagnosis / Q000276:immunology*; D020335:Paraparesis / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D010956:Plasmapheresis; D013116:Spinal Cord / Q000276:immunology* / Q000473:pathology* / Q000503:physiopathology; D013997:Time Factors; D016896:Treatment Outcome
C496030:AQP4 protein, human; D051401:Aquaporin 4; D001323:Autoantibodies; D015415:Biomarkers; D008775:Methylprednisolone